DE3445010A1 - Kontroll- bzw. eichserum fuer die lipid-diagnostik - Google Patents

Kontroll- bzw. eichserum fuer die lipid-diagnostik

Info

Publication number
DE3445010A1
DE3445010A1 DE19843445010 DE3445010A DE3445010A1 DE 3445010 A1 DE3445010 A1 DE 3445010A1 DE 19843445010 DE19843445010 DE 19843445010 DE 3445010 A DE3445010 A DE 3445010A DE 3445010 A1 DE3445010 A1 DE 3445010A1
Authority
DE
Germany
Prior art keywords
serum
control
calibration
cholesterol
lipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19843445010
Other languages
German (de)
English (en)
Inventor
Knut Dr Rer Nat Bartl
Rudolf Dr Rer Nat Portenhauser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6252384&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3445010(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Priority to DE19843445010 priority Critical patent/DE3445010A1/de
Priority to US06/800,460 priority patent/US4701417A/en
Priority to EP85115384A priority patent/EP0184765B1/de
Priority to DE8585115384T priority patent/DE3582723D1/de
Priority to AT85115384T priority patent/ATE63168T1/de
Priority to JP60276183A priority patent/JPS61142467A/ja
Priority to ES549777A priority patent/ES8605644A1/es
Publication of DE3445010A1 publication Critical patent/DE3445010A1/de
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material
    • G01N2496/05—Reference solutions for assays of biological material containing blood cells or plasma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/104165—Lipid, cholesterol, or triglyceride standard or control
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/106664—Blood serum or blood plasma standard or control
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331—Preservative, buffer, anticoagulant or diluent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
DE19843445010 1984-12-10 1984-12-10 Kontroll- bzw. eichserum fuer die lipid-diagnostik Ceased DE3445010A1 (de)

Priority Applications (7)

Application Number Priority Date Filing Date Title
DE19843445010 DE3445010A1 (de) 1984-12-10 1984-12-10 Kontroll- bzw. eichserum fuer die lipid-diagnostik
US06/800,460 US4701417A (en) 1984-12-10 1985-11-21 Control or calibration serum for lipid diagnosis
EP85115384A EP0184765B1 (de) 1984-12-10 1985-12-04 Kontroll- bzw. Eichserum für die Lipid-Diagnostik
DE8585115384T DE3582723D1 (de) 1984-12-10 1985-12-04 Kontroll- bzw. eichserum fuer die lipid-diagnostik.
AT85115384T ATE63168T1 (de) 1984-12-10 1985-12-04 Kontroll- bzw. eichserum fuer die lipiddiagnostik.
JP60276183A JPS61142467A (ja) 1984-12-10 1985-12-10 脂質診断学用の管理血清もしくは検定用血清及びその製造法
ES549777A ES8605644A1 (es) 1984-12-10 1985-12-10 Procedimiento para la preparacion de un suero de control o calibrado

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843445010 DE3445010A1 (de) 1984-12-10 1984-12-10 Kontroll- bzw. eichserum fuer die lipid-diagnostik

Publications (1)

Publication Number Publication Date
DE3445010A1 true DE3445010A1 (de) 1986-06-19

Family

ID=6252384

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19843445010 Ceased DE3445010A1 (de) 1984-12-10 1984-12-10 Kontroll- bzw. eichserum fuer die lipid-diagnostik
DE8585115384T Expired - Lifetime DE3582723D1 (de) 1984-12-10 1985-12-04 Kontroll- bzw. eichserum fuer die lipid-diagnostik.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE8585115384T Expired - Lifetime DE3582723D1 (de) 1984-12-10 1985-12-04 Kontroll- bzw. eichserum fuer die lipid-diagnostik.

Country Status (6)

Country Link
US (1) US4701417A (enExample)
EP (1) EP0184765B1 (enExample)
JP (1) JPS61142467A (enExample)
AT (1) ATE63168T1 (enExample)
DE (2) DE3445010A1 (enExample)
ES (1) ES8605644A1 (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593894A (en) * 1990-01-11 1997-01-14 Research Corporation Technologies, Inc. Direct cholesterol assay
US5547873A (en) * 1994-02-22 1996-08-20 Genzyme Corporation Compositions for stabilizing proteins for long term dry storage and methods of making and using the compositions
US5621094A (en) * 1990-05-14 1997-04-15 Quadrant Holdings Cambridge Limited Method of preserving agarose gel structure during dehydration by adding a non-reducing glycoside of a straight-chain sugar alcohol
DE4135404A1 (de) * 1991-10-26 1993-04-29 Boehringer Mannheim Gmbh Stabiles fluessiges kontroll- bzw. eichserum fuer die klinische diagnostik
EP0679088B1 (en) 1992-09-29 2002-07-10 Inhale Therapeutic Systems Pulmonary delivery of active fragments of parathyroid hormone
AT399056B (de) * 1993-03-19 1995-03-27 Immuno Ag Lyophilisiertes kontroll- oder referenzplasma bzw. kontroll- oder referenzserum für diagnostische zwecke
ATE416755T1 (de) 1994-03-07 2008-12-15 Nektar Therapeutics Verfahren und zusammensetzung für die pulmonale darreichung von insulin
US5955448A (en) 1994-08-19 1999-09-21 Quadrant Holdings Cambridge Limited Method for stabilization of biological substances during drying and subsequent storage and compositions thereof
DE69530196T2 (de) * 1994-06-02 2003-11-20 Elan Drug Delivery Ltd Methode zum verhindern der aggregation von proteinen/peptiden bei rehydratation oder auftauen
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
US6586006B2 (en) 1994-08-04 2003-07-01 Elan Drug Delivery Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
EP0778949B1 (en) * 1994-08-31 1999-05-12 Bio-Rad Laboratories, Inc. Stable substitute tryglycerides for use in clinical chemistry assay controls or calibrators and process for their preparation
JPH10508744A (ja) 1994-09-22 1998-09-02 クオドラント ホールディングス ケンブリッジ リミテッド 運動競技の間の水分補給および栄養摂取の用途のための組成物ならびにその製造法
ATE223060T1 (de) * 1994-11-28 2002-09-15 Abbott Lab Stabile wässrige steroid-standardproben für immuntests
US5614414A (en) * 1995-03-30 1997-03-25 Streck Laboratories, Inc. Liquid lipoprotein control
US5770451A (en) * 1995-03-30 1998-06-23 Streck Laboratories, Inc. Liquid lipoprotein control
US6964771B1 (en) * 1995-06-07 2005-11-15 Elan Drug Delivery Limited Method for stably incorporating substances within dry, foamed glass matrices
US5958455A (en) * 1996-02-09 1999-09-28 Quadrant Holdings Cambridge Ltd Oral solid dosage forms, methods of making same and compositions thereof
US5762961A (en) * 1996-02-09 1998-06-09 Quadrant Holdings Cambridge Ltd. Rapidly soluble oral solid dosage forms, methods of making same, and compositions thereof
US6632648B1 (en) 1996-05-14 2003-10-14 Elan Drug Delivery Limited Methods of terminal sterilization of fibrinogen
DE19654266A1 (de) * 1996-12-23 1998-06-25 Albrecht Prof Dr Wendel Untersuchungsverfahren mit biologischem System
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
PT1280520E (pt) 2000-05-10 2014-12-16 Novartis Ag Pós à base de fosfolípidos para administração de fármacos
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
AU2002349870A1 (en) * 2001-02-05 2003-04-01 The Board Of Regents For Oklahoma State University Direct serum lipids assays for evaluation of disease states
JP4574066B2 (ja) * 2001-06-06 2010-11-04 積水メディカル株式会社 Ｐｒｅβ１−ＨＤＬ測定用血液検体
PT1458360E (pt) 2001-12-19 2011-07-13 Novartis Ag Derivados de indole como agonistas do recetor s1p1
US7338802B2 (en) * 2002-10-30 2008-03-04 Radiometer Medical Aps Method of performing calibration and quality control of a sensor and apparatus for performing the method
US20050100636A1 (en) * 2003-11-10 2005-05-12 Megan Botteri [A Low-Calorie Sports Drink For Physically Active Women That is Fortified with Iron, Calcium and Essential Vitamins for Use in Rehydration and Replacing Electrolytes Lost During Periods of Physical Activity]
CA2579001C (en) * 2004-09-01 2014-07-08 Maine Standards Company, Llc Novel stable lipid standards
WO2006054519A1 (ja) * 2004-11-17 2006-05-26 Kyowa Medex Co., Ltd. リポ蛋白中成分の分別定量用標準品
JP5596964B2 (ja) * 2008-12-02 2014-09-24 協和メデックス株式会社 リポ蛋白中成分の分別定量用標準品の製造方法
CA2780301A1 (en) * 2009-11-13 2011-05-19 Bg Medicine, Inc. Risk factors and prediction of myocardial infarction
CN114279778A (zh) * 2021-12-04 2022-04-05 南京岚煜生物科技有限公司 一种复合高值参考品的制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3876375A (en) * 1971-11-22 1975-04-08 Jonas Maurukas Biological composition for use as a reference control in diagnostic analysis
US3955925A (en) * 1973-11-12 1976-05-11 Proksch Gary J Preparation of optically clear serum

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4011045A (en) * 1975-02-14 1977-03-08 Bonderman Dean P Turbidity reduction in triglyceride standards
US4039285A (en) * 1975-10-10 1977-08-02 Ortho Diagnostics, Inc. Single sample method for determination of lipoprotein concentrations in blood
US4105521A (en) * 1977-09-21 1978-08-08 Helena Laboratories Corporation Clinical procedure for measuring lipoprotein cholesterols
US4226713A (en) * 1978-04-24 1980-10-07 Goldberg Jack M Diagnostic agents
US4216117A (en) * 1978-05-15 1980-08-05 Bonderman Dean P Lipoprotein diluent or solution and method useful in the preparation of assay reference materials
DE2839433A1 (de) * 1978-09-11 1980-03-20 Merck Patent Gmbh Waessrige lipid-standardloesung und verfahren zu ihrer herstellung
US4210557A (en) * 1978-12-15 1980-07-01 Beckman Instruments, Inc. Non-high density lipoprotein precipitant
US4290774A (en) * 1980-01-07 1981-09-22 Miles Laboratories, Inc. Purification of lipoprotein cholesterol for use as a cholesterol reference material
DE3007764A1 (de) * 1980-02-29 1981-10-15 Boehringer Mannheim Gmbh Verfahren und reagens zur bestimmung der beta -lipoproteine
JPS5836954B2 (ja) * 1980-03-31 1983-08-12 栄研化学株式会社 酵素の安定化剤
DE3107060A1 (de) * 1981-02-25 1982-09-09 Boehringer Mannheim Gmbh, 6800 Mannheim Kontroll- oder eichserum und verfahren zu seiner herstellung
DE3133937A1 (de) * 1981-08-27 1983-03-17 Boehringer Mannheim Gmbh Verfahren zur bestimmung von ldl
US4438202A (en) * 1981-11-30 1984-03-20 Technicon Instruments Corporation Stable, base serum compositions and preparation thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3876375A (en) * 1971-11-22 1975-04-08 Jonas Maurukas Biological composition for use as a reference control in diagnostic analysis
US3876375B1 (enExample) * 1971-11-22 1992-11-03 Maurukas Jonas
US3955925A (en) * 1973-11-12 1976-05-11 Proksch Gary J Preparation of optically clear serum

Also Published As

Publication number Publication date
EP0184765A3 (en) 1988-03-30
DE3582723D1 (de) 1991-06-06
JPH0471468B2 (enExample) 1992-11-13
ES8605644A1 (es) 1986-04-01
ES549777A0 (es) 1986-04-01
EP0184765A2 (de) 1986-06-18
ATE63168T1 (de) 1991-05-15
EP0184765B1 (de) 1991-05-02
US4701417A (en) 1987-10-20
JPS61142467A (ja) 1986-06-30

Similar Documents

Publication Publication Date Title
DE3445010A1 (de) Kontroll- bzw. eichserum fuer die lipid-diagnostik
DE69033033T2 (de) Verbesserte kontrollverfahren für stabile blutkoagulation
DE3021006C2 (de) Oberflächenaktives Material und dieses Material enthaltendes pharmazeutisches Mittel gegen Hyalin-Membran-Erkrankung
DE3017152A1 (de) Mittel fuer die herstellung einer blut-vergleichsueberwachung, verfahren zu ihrer herstellung und verduennung hierfuer
EP0021152A1 (de) Verfahren zur immunologischen Bestimmung von Basalmembranmaterial, hierfür geeignete Basalmembranfragmente und Verfahren zu deren Herstellung, bzw. Gewinnung
DE68912115T2 (de) Ausscheidungsverfahren für die herstellung von thromboplastinreagenzien.
EP0058959B1 (de) Verfahren zur Herstellung von trübgasarmen Eich- oder Kontrollseren
DE2806430A1 (de) Verfahren zum nachweis und zur bestimmung des lipoproteins lp-x im serum
DE69722900T2 (de) Verfahren zur Herstellung von einer stabilen Troponin-Zubereitung und ihre Verwendung als Kalibrator/Kontrolle in Immunoassays
DE3875854T2 (de) Auf ligninsulfonat aufgebautes pharmazeutisches mittel mit einer atithrombose-aktivitaet.
EP0145005B1 (de) Lungen-Surfactant, Verfahren zu seiner Herstellung und seine pharmazeutische Verwendung
DE68912477T3 (de) Verfahren zum messen der biologischen wirkung von antithrombin iii und reagenzkit zu dessen messung
EP0141922B1 (de) Verfahren zur Verringerung einer Trübung in Kontrollseren
DE2850950C3 (de) Verwendung von nativem oder thermisch modifiziertem Cytochrom c als Stabilisator für ein immunochemisches Meßreagens, immunochemisches Meßreagens sowie Pufferlösung zur Probenverdünnung bei immunchemischen Meßverfahren
EP1242825B1 (de) Gewinnung von lipoproteinen aus körperflüssigkeiten
DE60222149T2 (de) Referenzkontrolle für hochempfindliche tests des c-reaktiven proteins
EP0119990B1 (de) Verfahren zur Herstellung von therapeutisch verabreichbaren, in Endbehältern abgefüllten Plasmaderivaten
DE2256331A1 (de) Verfahren zur harnsaeurebestimmung
DE69017825T2 (de) Heilverfahren von Lebererkrankungen mit Verwendung von Pyrrol-Chinolin-Chinone-Triester und neue Pyrrol-Chinolin-Chinone-Triester.
EP0020895A1 (de) Partielles Thromboplastin
EP0337466B1 (de) Verfahren zur Bestimmung der Thyroxinbindekapazität und dazu geeignete Standardlösung
DE68903670T2 (de) Physiologisch aktive, fluessige, allergenische zusammensetzungen aus biologischen rohmaterialien.
EP0727434B1 (de) Reinigung von Gewebefaktor
DE1247704B (de) Verfahren zur Herstellung einer hoch Chloesterin haltigen Kontroll-Standard-Loesung fuer die Bestimmung des Blutcholesterinspiegels
DE2550011A1 (de) Antihaemophiles mittel und verfahren zu dessen herstellung

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8131 Rejection